Skip to main content
. 2025 Oct 15;14(20):7271. doi: 10.3390/jcm14207271
AUC Area Under the Curve
BC Breast Cancer
CAR C-reactive Protein-to-Albumin Ratio
CI Confidence Interval
DFS Disease-Free Survival
ECOG Eastern Cooperative Oncology Group
ER Estrogen Receptor
FISH Fluorescence In Situ Hybridization
HER2 Human Epidermal Growth Factor Receptor 2
IHC Immunohistochemistry
Ki-67 Ki-67 Proliferation Index
LMR Lymphocyte-to-Monocyte Ratio
NAR Neutrophil-to-Albumin Ratio
NAT Neoadjuvant Therapy
NLR Neutrophil-to-Lymphocyte Ratio
OR Odds Ratio
OS Overall Survival
pCR Pathological Complete Response
PLR Platelet-to-Lymphocyte Ratio
PNI Prognostic Nutritional Index
PR Progesterone Receptor
RC Reference Category
ROC Receiver Operating Characteristic
SII Systemic Immune-Inflammation Index